BioCentury
ARTICLE | Emerging Company Profile

Corporate Profile

March 17, 2008 7:00 AM UTC

Baltimore, Md.

Technology: Vaccines against conserved regions of HIV envelope proteins and small molecule NF-kappa B modulators to treat HIV...